1. Molecular Pathology of Cervical Dysplasia and Carcinoma
    Yimin Ge et al, 2017, Precision Molecular Pathology of Uterine Cancer CrossRef
  2. poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells
    Xueqiong Meng et al, 2022, Translational Oncology CrossRef
  3. Live cell, image-based high-throughput screen to quantitate p53 stabilization and viability in human papillomavirus positive cancer cells
    Gustavo Martínez-Noël et al, 2021, Virology CrossRef
  4. Enhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132
    Yoko Matsumoto et al, 2016, Cancer Science CrossRef
  5. Perspectives on targeting the phosphatidylinositol 3-kinase pathway for personalized medicine in endometrial and ovarian cancers
    Katsutoshi Oda et al, 2016, Personalized Medicine Universe CrossRef
  6. In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity
    Steve Seltzsam et al, 2019, Translational Oncology CrossRef
  7. Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells
    Xinmiao Yang et al, 2014, Cancer Cell International CrossRef
  8. Proteasome inhibition prevents cell death induced by the chemotherapeutic agent cisplatin downstream of DNA damage
    Ana Rita Costa et al, 2019, DNA Repair CrossRef
  9. Synergic effect of anticancer peptide CIGB-552 and Cisplatin in lung cancer models
    Yolanda Gomez Rodriguez et al, 2022, Molecular Biology Reports CrossRef
  10. Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells
    Ting Zhang et al, 2017, Molecular Medicine Reports CrossRef
  11. Cisplatin-induced cell death in Saccharomyces cerevisiae is programmed and rescued by proteasome inhibition
    Dulce Cunha et al, 2013, DNA Repair CrossRef
  12. Emerging Cancer Therapeutic Targets in Protein Homeostasis
    Prabhakar Bastola et al, 2018, The AAPS Journal CrossRef
  13. Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer
    L.H. Cossar et al, 2017, Clinical Oncology CrossRef
  14. Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis
    Jayne Knoff et al, 2014, Current Obstetrics and Gynecology Reports CrossRef
  15. IL‑8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells
    Linlin Jia et al, 2017, Oncology Letters CrossRef